The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 21, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Gestational Diabetes MellitusContinuous Glucose Monitoring
Interventions
DEVICE

Continuous glucose monitor

"Participants will receive a set of continuous glucose monitor (CGM) at 24-32 weeks of pregnancy (first set); and 33 weeks of pregnancy to before delivery (second set) respectively.~CGM wearing instruction will be provided before the first wearing at 24-32 weeks of pregnancy. After completing the first wearing (approximately 7-14 days after starting to wear), the investigators will provide glucose monitor reports. The second CGM was worn from the 33rd week of pregnancy to before delivery, and another glucose monitor reports was given approximately 7-14 days after starting to wear."

BEHAVIORAL

Perinatal nursing care for gestational diabetes

Individual nursing care and consultation for women with gestational diabetes mellitus, including glucose monitor suggestions, dietary suggestions, emotional support, breastfeeding support at 24-32 weeks of pregnancy, 33 weeks of pregnancy to before delivery, and 4-12 weeks postpartum.

OTHER

Blood glucose meters (BGM)

Participants are required to use blood glucose meters (BGM) at 24-32 weeks of pregnancy and 33 weeks to before delivery. After 7-14 days of glucose monitoring at 24-32 weeks of pregnancy, glucose monitor reports will be given to the participants. After the 7-14 days of glucose monitoring at 33 weeks to before delivery, another glucose monitor reports will be given to the participants.

Trial Locations (1)

302058

National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital, Hsinchu

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06648174 - The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter